Ubs Group Ag Avita Medical, Inc. Transaction History

Ubs Group Ag

$611 Billion
Q3 2025

A detailed history of Ubs Group Ag transactions in Avita Medical, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 75,400 shares of RCEL stock, worth $282,750. This represents 0.0% of its overall portfolio holdings.

Number of Shares

75,400

Previous 409,799 81.6%

Holding current value

$282,750

Previous $2.17 Million 82.33%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$4.17 - $6.76 $1.39 Million - $2.26 Million	-334,399 Reduced 81.6%	75,400 $383,000
Q2 2025 Aug 14, 2025	BUY	$4.77 - $10.25 $310,388 - $666,977	65,071 Added 18.88%	409,799 $2.17 Million
Q1 2025 May 13, 2025	BUY	$8.14 - $13.72 $1.76 Million - $2.96 Million	216,098 Added 168.0%	344,728 $2.81 Million
Q4 2024 Feb 14, 2025	BUY	$9.89 - $13.7 $1.1 Million - $1.52 Million	110,824 Added 622.4%	128,630 $1.65 Million
Q3 2024 Nov 14, 2024	BUY	$7.72 - $10.87 $5,295 - $7,456	686 Added 4.01%	17,806 $190,000

Q2 2024 Aug 13, 2024	SELL	$7.92 - $15.55 $272,416 - $534,857	-34,396 Reduced 66.77%	17,120 $135,000
Q1 2024 May 13, 2024	BUY	$12.56 - $18.31 $395,753 - $576,929	31,509 Added 157.49%	51,516 $825,000
Q4 2023 Feb 09, 2024	BUY	$9.29 - $14.57 $67,426 - $105,749	7,258 Added 56.93%	20,007 $274,000
Q3 2023 Nov 09, 2023	SELL	$13.84 - $20.79 $65,449 - $98,315	-4,729 Reduced 27.06%	12,749 $186,000
Q2 2023 Aug 11, 2023	BUY	$10.7 - $17.48 $122,728 - $200,495	11,470 Added 190.91%	17,478 $297,000
Q1 2023 May 12, 2023	BUY	$6.45 - $14.48 $34,068 - $76,483	5,282 Added 727.55%	6,008 $83,000
Q4 2022 Feb 08, 2023	BUY	$4.53 - $7.55 $2,156 - $3,593	476 Added 190.4%	726 $4,000
Q3 2022 Nov 10, 2022	SELL	$4.97 - $7.89 $5,084 - $8,071	-1,023 Reduced 80.36%	250 $1,000
Q2 2022 Aug 10, 2022	SELL	$4.6 - $8.82 $625 - $1,199	-136 Reduced 9.65%	1,273 $6,000
Q1 2022 May 16, 2022	SELL	$6.96 - $12.15 $249,307 - $435,213	-35,820 Reduced 96.22%	1,409 $13,000
Q4 2021 Feb 14, 2022	BUY	$11.72 - $19.66 $246,612 - $413,685	21,042 Added 129.99%	37,229 $445,000
Q3 2021 Nov 15, 2021	BUY	$16.73 - $20.9 $250,732 - $313,228	14,987 Added 1248.92%	16,187 $287,000
Q2 2021 Aug 13, 2021	SELL	$17.23 - $22.02 $222,646 - $284,542	-12,922 Reduced 91.5%	1,200 $25,000
Q1 2021 May 12, 2021	BUY	$18.38 - $28.41 $225,540 - $348,619	12,271 Added 662.94%	14,122 $280,000
Q4 2020 Feb 11, 2021	BUY	$17.55 - $27.2 $28,975 - $44,907	1,651 Added 825.5%	1,851 $35,000
Q3 2020 Nov 12, 2020	SELL	$20.83 - $30.0 $19,975 - $28,770	-959 Reduced 82.74%	200 $5,000
Q2 2020 Jul 31, 2020	BUY	$26.1 - $34.6 $30,249 - $40,101	1,159 New	1,159 $35,000

Others Institutions Holding RCEL

# of Institutions

Shares Held

5.81M

Call Options Held

77.4K

Put Options Held

19.4K

View Full List

About AVITA Medical, Inc.

Ticker RCEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,030,900
Market Cap $93.9M
Description
AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...

More about RCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account